iSERA Lifesciences Limited (BOM:534920)
143.90
0.00 (0.00%)
At close: Jul 31, 2026
iSERA Lifesciences Market Cap
iSERA Lifesciences has a market cap or net worth of 1.21 billion as of July 31, 2026. Its market cap has increased by 124,199.02% in one year.
Market Cap
1.21B
Enterprise Value
1.20B
Revenue
13.69M
Ranking
n/a
PE Ratio
466.48
Stock Price
143.90
ChartMarket Cap Chart
Since February 6, 2013, iSERA Lifesciences's market cap has increased from 232.92M to 1.21B, an increase of 419.51%. That is a compound annual growth rate of 12.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.21B | 747.47% |
| Dec 31, 2025 | 142.78M | -19.78% |
| Dec 26, 2023 | 178.00M | 45,541.03% |
| Dec 26, 2022 | 390.00K | -96.13% |
| Dec 27, 2021 | 10.07M | 41.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intense Technologies | 1.97B |
| Virinchi | 1.74B |
| Trigyn Technologies | 1.65B |
| Genxai Analytics | 1.37B |
| RNIT Al Solutions | 1.20B |
| Emiac Technologies | 1.18B |
| Mobilise App Lab | 1.08B |
| Newtime Infrastructure | 1.04B |